Sphera Funds Management’s Crinetics Pharmaceuticals CRNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
2023
Q1
$1.33M Sell
2022
Q4
$12.3M Buy
2022
Q3
$12.3M Buy
2022
Q2
$10.9M Buy
2022
Q1
$11.5M Buy
2021
Q4
$12M Sell
2021
Q3
$11.5M Sell
2021
Q2
$12M Buy
2021
Q1
$4.34M Buy